BackgroundCheck.run
Search For

Ryan S Burnett, 521512 Grove St, San Diego, CA 92102

Known as:
Ryan Burett Burnett S Ryan
Related to:
Kori R Williams 52 Ryan P Dent 50 Edna L Burnett Dean Burnett Ronald M Burnett 92 Carrie D Steele 51 Connie L Viera 47 Kelly C Steele 57 Ryan C Steele 52

Ryan Burnett Phones & Addresses

1512 Grove St, San Diego, CA 92102    858-2005595   

3939 Illinois St, San Diego, CA 92104    619-5630369   

5285 Toscana Way, San Diego, CA 92122    858-4535497   

8680 Via Mallorca, La Jolla, CA 92037    858-4535497   

Escondido, CA   

Decatur, GA   

Smyrna, GA   

1512 Grove St, San Diego, CA 92102   

Work

Position: Professional/Technical
Get Report
Control this profile

Mentions for Ryan S Burnett

Ryan Burnett resumes & CV records

Resumes

Ryan Burnett Photo 56

Director, Biologics Analytical Development

Location:
1512 Grove St, San Diego, CA 92102
Industry:
Biotechnology
Work:
Tocagen Inc.
Associate Director, Product Development Tocagen Inc. Apr 2016 - Mar 2018
Principal Scientist Tocagen Inc. Apr 2013 - Apr 2016
Research Scientist Iii Tocagen Inc. Apr 2011 - Apr 2013
Research Scientist Ii Tocagen Inc. Jun 2008 - Apr 2011
Research Scientist The Scripps Research Institute Jun 2002 - Jun 2008
Senior Research Fellow Jun 2002 - Jun 2008
Director, Biologics Analytical Development
Education:
Georgia Institute of Technology 1995 - 2002
Doctorates, Doctor of Philosophy, Biochemistry Indiana University Bloomington 1990 - 1995
Bachelors, Bachelor of Science, Biochemistry Scripps Research
Mooresville High School
Indiana University (Bloomington)
Bachelors, Bachelor of Science, Biochemistry Georgia Tech
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry
Skills:
Assay Development, Molecular Biology, Cell, Protein Chemistry, Protein Purification, Cell Culture, Elisa, Biophysics, Qpcr, Viral Vectors, Life Sciences, Cell Biology, Tissue Culture, Biotechnology, Technology Transfer, Transfection, In Vivo, Western Blotting, Product Development, Flow Cytometry, Drug Discovery, Gene Therapy, Quality Control, Validation, Gmp, In Vitro, Sds Page, Purification, Biochemistry, Immunology, Translational Science, Project Management, Cross Functional Team Leadership, Business Operations, Chemistry, Team Building, Program Management, Cmc Development, Quality System, Reverse Transcription Polymerase Chain Reaction, Cancer Research, Drug Development, Biopharmaceuticals
Languages:
English
Ryan Burnett Photo 57

Research Scientist

Location:
San Diego, CA
Industry:
Biotechnology
Work:
Tocagen Inc.
Research Scientist

Publications & IP owners

Us Patents

Small Molecule Therapeutics And Uses Therefor

US Patent:
2006027, Nov 30, 2006
Filed:
May 2, 2006
Appl. No.:
11/416381
Inventors:
Christian Melander - Raleigh NC, US
Ryan Burnett - San Diego CA, US
Peter Dervan - San Marino CA, US
Joel Gottesfeld - Del Mar CA, US
International Classification:
A61K 31/4178
US Classification:
514397000
Abstract:
The invention provides polyamides which bind genes having expanded oligonucleotide repeat sequences, which binding modulates transcription. The invention further provides methods of modulation of the transcription of such genes, and the use of polyamides as therapeutic agents to treat diseases associated with such genes.

Histone Deacetylase Inhibitors As Therapeutics For Neurological Diseases

US Patent:
2007021, Sep 20, 2007
Filed:
Nov 10, 2006
Appl. No.:
11/595779
Inventors:
Kai Jenssen - Frankfurt am Main, DE
David Herman - San Diego CA, US
Joel Gottesfeld - Del Mar CA, US
Ryan Burnett - San Diego CA, US
C. Chou - San Diego CA, US
Assignee:
The Scripps Research Institute - La Jolla CA
International Classification:
A61K 31/4709
A61K 31/444
A61K 31/165
C07D 401/02
US Classification:
514313000, 514352000, 514616000, 546159000, 546265000, 546309000, 564152000
Abstract:
The invention provides HDAC inhibitors that may be used as therapeutics for the treatment of a neurodegenerative or neuromuscular condition. The invention provides compounds of formula I: The invention also provides pharmaceutical compositions and articles of manufacture that include these compounds, as well as methods of treating and methods of preventing or delaying the onset of a neurodegenerative or neuromuscular condition.

Treatment Of Friedreich's Ataxia Using Histone Deacetylase Inhibitors

US Patent:
2011002, Jan 27, 2011
Filed:
May 4, 2010
Appl. No.:
12/773032
Inventors:
KAI JENSSEN - SAN DIEGO CA, US
DAVID M. HERMAN - SAN DIEGO CA, US
JOEL M. GOTTESFELD - DEL MAR CA, US
RYAN BURNETT - SAN DIEGO CA, US
C. JAMES CHOU - SAN DIEGO CA, US
Assignee:
THE SCRIPPS RESEARCH INSTUTE - LA JOLLA CA
International Classification:
A61K 31/167
A61K 31/4402
A61K 31/47
C07C 231/02
C07D 213/75
C07D 215/38
A61P 25/00
US Classification:
514313, 514616, 514352, 514311, 564138, 546309, 546171, 546162
Abstract:
The invention provides methods of treating Friedreich's ataxia using histone deacetylase inhibitors.

Treatment Of Friedreich's Ataxia Using Histone Deacetylase Inhibitors

US Patent:
2013021, Aug 15, 2013
Filed:
Apr 15, 2013
Appl. No.:
13/862727
Inventors:
Joel M. Gottesfeld - Del Mar CA, US
Kai Jenssen - San Diego CA, US
David M. Herman - San Diego CA, US
Ryan Burnett - San Diego CA, US
C. James Chou - San Diego CA, US
Assignee:
The Scripps Research Institute - La Jolla CA
International Classification:
C07C 233/29
C07C 231/00
C07C 233/44
US Classification:
514616, 564139
Abstract:
The invention provides methods of treating Friedreich's ataxia using histone deacetylase inhibitors.

Enhanced Cancer Treatment And Monitoring Using Recombinant Vectors

US Patent:
2013032, Dec 5, 2013
Filed:
Oct 31, 2011
Appl. No.:
13/882487
Inventors:
Harry E. Gruber - Rancho Santa Fe CA, US
Douglas J. Jolly - Encinitas CA, US
Derek G. Ostertag - San Diego CA, US
Ryan S. Burnett - San Diego CA, US
Amy H. Lin - San Diego CA, US
Tiffany Huang - San Diego CA, US
Joan M. Robbins - San Diego CA, US
Assignee:
TOCAGEN INC. - San Diego CA
International Classification:
A61K 31/7088
A61K 31/573
A61N 5/10
A61K 9/127
A61K 31/713
A61K 39/395
A61K 31/58
US Classification:
424450, 514169, 424 932, 514 44 R, 4241741, 4241581, 514179, 514180, 514174, 514 44 A, 600 1
Abstract:
This disclosure relates to replication competent viral vectors for treating cell proliferative disorders. The disclosure further relates to the use of such replication competent viral vectors for delivery and expression of a heterologous nucleic acid in normal and diseased tissues and methods and compositions that facilitate such delivery and expression to tissues in vivo and in vitro. The disclosure further relates to replication competent retroviral vectors for these uses and in conjunction with methods and compositions that facilitate in vivo therapeutics.

Methods Of Treating Cancer By Inhibiting Histone Gene Expression

US Patent:
2006001, Jan 26, 2006
Filed:
Apr 27, 2005
Appl. No.:
11/116959
Inventors:
Peter Dervan - San Marino CA, US
Liliane Dickinson - San Diego CA, US
Paramjit Arora - New York NY, US
Ryan Burnett - San Diego CA, US
Joel Gottesfeld - Del Mar CA, US
International Classification:
A61K 31/52
A61K 31/4178
US Classification:
514263200, 514397000
Abstract:
Methods are provided for decreasing the rate or inhibiting neoplastic cell proliferation by reducing or inhibiting histone H4 gene expression or histone H4 activity. Also provided are methods of treating a patient with a neoplastic disease, and compositions useful for treating a cancer patient, including, for example, a composition containing small interfering RNA molecules that reduce or inhibit histone H4 expression in a cell or a composition containing a pyrrole-imidazole polyamide operatively linked to a chemotherapeutic molecule.

Enhanced Cancer Treatment And Monitoring Using Recombinant Vectors

US Patent:
2021036, Nov 25, 2021
Filed:
Mar 1, 2021
Appl. No.:
17/189169
Inventors:
- San Diego CA, US
Douglas J. Jolly - Encinitas CA, US
Derek G. Ostertag - San Diego CA, US
Ryan S. Burnett - San Diego CA, US
Amy H. Lin - San Diego CA, US
Tiffany Huang - San Diego CA, US
Joan M. Robbins - San Diego CA, US
Assignee:
DENOVO BIOPHARMA, LLC - San Diego CA
International Classification:
A61K 31/7088
A61K 39/21
C12N 15/867
A61K 31/56
A61K 39/395
A61K 35/768
A61K 9/127
A61K 31/573
A61K 31/58
A61K 31/713
A61N 5/10
Abstract:
This disclosure relates to replication competent viral vectors for treating cell proliferative disorders. The disclosure further relates to the use of such replication competent viral vectors for delivery and expression of a heterologous nucleic acid in normal and diseased tissues and methods and compositions that facilitate such delivery and expression to tissues in vivo and in vitro. The disclosure further relates to replication competent retroviral vectors for these uses and in conjunction with methods and compositions that facilitate in vivo therapeutics.

Enhanced Cancer Treatment And Monitoring Using Recombinant Vectors

US Patent:
2018002, Jan 25, 2018
Filed:
Jun 1, 2017
Appl. No.:
15/611722
Inventors:
- San Diego CA, US
Douglas J. Jolly - Encinitas CA, US
Derek G. Ostertag - San Diego CA, US
Ryan S. Burnett - San Diego CA, US
Amy H. Lin - San Diego CA, US
Tiffany Huang - San Diego CA, US
Joan M. Robbins - San Diego CA, US
International Classification:
A61K 31/7088
C12N 15/867
A61N 5/10
A61K 39/395
A61K 31/573
A61K 39/21
A61K 35/768
A61K 31/713
A61K 31/58
A61K 9/127
A61K 31/56
Abstract:
This disclosure relates to replication competent viral vectors for treating cell proliferative disorders. The disclosure further relates to the use of such replication competent viral vectors for delivery and expression of a heterologous nucleic acid in normal and diseased tissues and methods and compositions that facilitate such delivery and expression to tissues in vivo and in vitro. The disclosure further relates to replication competent retroviral vectors for these uses and in conjunction with methods and compositions that facilitate in vivo therapeutics.

Possible Relatives

Cynthia J Burnett  David B Burnett  A W Burnett  Dahlia T Burnett  Debora S Burnett  Damon J Burnett  Deborah L Burnett  Ryan A Johnson  Ryan Stamps  Ryan F Stander 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.